Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.950
-0.040 (-2.01%)
At close: Apr 7, 2026, 4:00 PM EDT
2.010
+0.060 (3.09%)
After-hours: Apr 7, 2026, 7:48 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.68 million as of April 7, 2026. Its market cap has increased by 11.55% in one year.
Market Cap
3.68M
Enterprise Value
-996.80K
1-Year Change
11.55%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $3.68M, a decrease of -100.00%. That is a compound annual growth rate of -86.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 3.76M | 1.11% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 4.65M |
| VivoSim Labs | 4.41M |
| Silexion Therapeutics | 4.03M |
| Alzamend Neuro | 3.80M |
| Azitra | 3.80M |
| Indaptus Therapeutics | 3.59M |
| Galmed Pharmaceuticals | 3.55M |
| Matinas BioPharma Holdings | 3.50M |